Bioactive Compounds
-
BA3001 MRIA9Summary: MRIA9 is a competitive inhibitor of ATP. - BA1818 BicyclolSummary: Bicyclol (SY801) is an orally available anti-HBV.
- BA2983 BatabulinSummary: Batabulin (T138067) is an antitumor agent that covalently and selectively binds to a subset of beta-microtubule protein isoforms, thereby disrupting microtubule polymerization.
- BA1817 MorphothiadinSummary: Morphothiadin is a potent inhibitor of wild-type and adefovir-resistant replication.
- BA2973 IndibulinSummary: Indibulin (ZIO301), an orally effective synthetic inhibitor with good anticancer activity and minimal neurotoxicity.
- BA1816 EntecavirSummary: Entecavir (SQ34676;BMS200475) is a selective and potent inhibitor.
- BA2942 LCH-7749944Summary: LCH-7749944 (GNF-PF-2356) is a potent inhibitor.
- BA1815 RG7834Summary: RG7834 (RO7020322) is a highly selective, orally available inhibitor.
- BA2911 IrigeninSummary: Irigenin is a lead compound that mediates its anti-metastatic effects by specifically and selectively blocking the ExtraDomainA (EDA) domain on the C-C loop and at integrin binding sites.
- BA1814 SelgantolimodSummary: Selgantolimod (GS-9688) is orally active.